Stealth’s Elamipretide: Is A New Preapproval Trial Feasible?

Trash out the window
One adcomm member said approving elamipretide now would be throwing away the opportunity for future studies. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from US Advisory Committees